Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SYHD001
- Development stage
- Unknown
- Lead developer
- Sanyou Biopharmaceuticals
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
SYHD001 is an antibody-drug conjugate (ADC) developed for the treatment of cancer. It is designed as a targeted therapy, combining an antibody that specifically binds to cancer cells with a cytotoxic agent, enabling selective delivery of the cytotoxic payload to tumor tissue while minimizing damage to healthy cells. SYHD001 was co-developed by Sanyou Biopharmaceuticals and Huadong Medicine, with Sanyou Bio contributing their technology platforms and R&D capabilities. SYHD001 has entered Phase I clinical trials, indicating its initial evaluation for safety in humans[1][3][7][13]. Specific target and payload details have not been publicly disclosed, but available descriptions and context suggest its application in oncology as an ADC with high technical demands and development complexity.
- Brand names
- SYHD001SYHD-001SYHD 001
- Other names
- SYHD001SYHD-001SYHD 001
Beyond the preview
Go deeper on SYHD001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYHD001.